Gunderson Capital Management Inc. Zoetis Inc. Transaction History

Gunderson Capital Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$92.66 - $144.94 $418,545 - $654,693	-4,517 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$116.25 - $133.25 $160,657 - $184,151	1,382 Added 44.08%	4,517 $598,000
Q3 2019 Nov 14, 2019	SELL	$112.57 - $128.43 $19,474 - $22,218	-173 Reduced 5.23%	3,135 $391,000
Q2 2019 Nov 14, 2019	BUY	$97.98 - $114.28 $783 - $914	8 Added 0.24%	3,308 $375,000
Q1 2019 Nov 14, 2019	BUY	$81.56 - $100.67 $269,148 - $332,211	3,300 New	3,300 $332,000

1,957

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Gunderson Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Gunderson Capital Management Inc. with notifications on news.